Ipsol Parenterals Private Limited

Ipsol Parenterals Private Limited - pharma in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U24299KA2022PTC158623 Incorporated 07 March 2022 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data
Registrar
Bangalore
ROC office

About Ipsol Parenterals Private Limited

Data last updated:

Ipsol Parenterals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 2022.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24299KA2022PTC158623.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudhir Kumar Chhatri and Prabir Parida.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Padmavathi Arcade No 16 Unit 2 And 3 2nd Floor 1st Main Road N R Colony, Bangalore, Karnataka, India – 560004.

Company Details of Ipsol Parenterals Private Limited
CIN U24299KA2022PTC158623
Registration Number 158623
Incorporation Date 07 March 2022
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Padmavathi Arcade No 16 Unit 2 And 3 2nd Floor 1st Main Road N R Colony, Bangalore, Karnataka, India – 560004
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Ipsol Parenterals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full report on Ipsol Parenterals

Financials, compliance, directors, charges, ownership and filings for Ipsol Parenterals Private Limited in one report.

Financials from FY 2022 Directors & ownership Charges & compliance

Financials of Ipsol Parenterals Private Limited

FY 2024 filings available

Financial Statement Summary

MetricsFY 2023-24FY 2021-22 to FY 2022-23in the company report
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA••••
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)••••
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios

MetricsFY 2023-24FY 2021-22 to FY 2022-23in the company report
Profitability
EBITDA Margin••••
Net Profit Margin••••
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots, and every line for FY 2021-22 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ipsol Parenterals are in the company report.

Premium access

Financial statements from FY 2022

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Board of Directors of Ipsol Parenterals Private Limited

Ipsol Parenterals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sudhir Kumar ChhatriDirector01 Dec 20232 Years 10 MonthsCurrent
Prabir ParidaDirector01 Dec 20232 Years 10 MonthsCurrent

Charges & Borrowings

Ipsol Parenterals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance

Employment history and EPFO contributions of people linked to Ipsol Parenterals.

Employee and EPFO history: available in the company report

Recent Activity

Ipsol Parenterals Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Surajman Vishvakarma ceased to be Director on 22 Dec 2023.

AGM
Ipsol Parenterals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Ipsol Parenterals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Ceased
Surajman Vishvakarma ceased to be Director.
Ceased
Umesh Rao Nagurao ceased to be Director.
Appointed
Prabir Parida was appointed as Director.
Appointed
Sudhir Kumar Chhatri was appointed as Director.
Incorporation
07 Mar 2022
Ipsol Parenterals Private Limited was registered on 07 Mar 2022 with Roc Bangalore & aged 4 years 7 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts

Credit ratings, litigation, and regulatory alerts: available in the company report

MSME Payment Delays

MSME payment history: available in the company report

Subsidiaries & Group Companies

Corporate group structure: available in the company report

GST Compliance

GST registrations and filing compliance: available in the company report

MCA Filings & Documents

MCA filings and documents: available in the company report

Frequently Asked Questions

Ipsol Parenterals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 2022 (4+ years old) and is registered under CIN U24299KA2022PTC158623.

Ipsol Parenterals has 2 current directors:

The latest financial statements of Ipsol Parenterals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Ipsol Parenterals is U24299KA2022PTC158623. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ipsol Parenterals was incorporated on 07 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.

Surajman Vishvakarma ceased to be Director on 22 Dec 2023. Umesh Rao Nagurao ceased to be Director on 22 Dec 2023. Prabir Parida was appointed as Director on 01 Dec 2023. Ipsol Parenterals has 4 board changes on record in total.

The registered office of Ipsol Parenterals is at Padmavathi Arcade No 16 Unit 2 And 3 2nd Floor 1st Main Road N R Colony, Bangalore, Karnataka, India – 560004.

Ipsol Parenterals operates in the pharma industry, in the drug formulation and development segment.

Ipsol Parenterals can be reached at its registered office: Padmavathi Arcade No 16 Unit 2 And 3 2nd Floor 1st Main Road N R Colony, Bangalore, Karnataka, India – 560004.

Ipsol Parenterals is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available